Matthew L. Baum
Brigham and Women's Hospital · 62 works · 4,839 citations · h-index 15
Top works
- Schizophrenia risk from complex variation of complement component 4
- Molecular Diversity and Specializations among the Cells of the Adult Mouse Brain
- Extrasynaptic NMDA Receptors Couple Preferentially to Excitotoxicity via Calpain-Mediated Cleavage of STEP
- Therapeutic Implications for Striatal-Enriched Protein Tyrosine Phosphatase (STEP) in Neuropsychiatric Disorders
- The Monoamine Oxidase A (MAOA) Genetic Predisposition to Impulsive Violence: Is It Relevant to Criminal Trials?
- Returning Individual Research Results from Digital Phenotyping in Psychiatry
- The Neuroethics of Biomarkers: What the Development of Bioprediction Means for Moral Responsibility, Justice, and the Nature of Mental Disorder
- How collaboration between bioethicists and neuroscientists can advance research
- Pharmacogenomic Clinical Support Tools for the Treatment of Depression
- Duties toward Patients with Psychiatric Illness
- Clinical Neuroscience
- Thyroid peroxidase antibodies in bipolar disorder: implications for clinical sub-phenotypes and lithium response
- The Neuroethics of Biomarkers
- CSMD1 regulates brain complement activity and circuit development
- Nudge Ethics: Just a Game of Billiards?
- CUB and Sushi Multiple Domains 1 (CSMD1) opposes the complement cascade in neural tissues
- A STEP forward in neural function and degeneration
- Behavioral Biomarkers: What Are They Good For?
- The ethical landscape of human brain organoids and a mindful innovation framework
- A Rational Basis for Chemoprevention of Prostate Cancer